The medical device group AdvaMed has formed a new digital health division focusing on lobbying lawmakers and the US Food and Drug Administration (FDA) on digital health regulations and legislation.
AdvaMed CEO Scott Whitaker announced the launch of AdvaMed Digital Health Tech on 9 October at the annual MedTech Conference. The new division will work on issues including artificial intelligence and machine learning (AI/ML) regulation and reimbursement.
AdvaMed has had a Center for Digital Health that focused on developing policies and strategies to assist digital health manufacturers for more than five years. As digital health has gained prominence in healthcare delivery, AdvaMed leadership concluded that the group needed to advance and present a public face…
